HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Board Certifications: Neurology
Languages: English and Korean
Locations: Hackensack, NJ
Call Hackensack, NJ: (551) 996-5900
Awards and Honors
Castle Connolly Top Doctors: 2021, 2022, 2023
Chicago Magazine Top Brain Doctors: 2022
American Society of Clinical Oncology: Career Development Award (Mentor: Merrill Egorin)
Research Award: Chordoma Foundation
Travel Award, AACR-ASCO Methods in Clinical Cancer Research Workshop
Hillman Foundation Fellow in Innovative Cancer Research
The Gregory T.H. Davies Chair in Brain Tumor Research and Physician Education
Professional Memberships
American College of Physicians
Scientific Advisory Board, The Chordoma Foundation
Scientific Advisor, Innate Repair
Medical Education
BA, History, Pacific Union College, Angwin, CA
MD, Loma Linda University, Loma Linda, CA
Post-Sophomore Fellow, Department of Pathology and Anatomy, Loma Lindam University, Loma Linda, CA
Neuro-Oncology Fellow, Memorial Sloan-Kettering Cancer Center, New York, NY
Postdoctoral Research Fellow in Immunology and Cell Biology, NINDS, National Institutes of Health, Bethesda, MD
Residency
Neurology Residency (Chief 1999-2000), University of Chicago, Chicago, IL
Fellowships
Neuro-Oncology Fellow, Memorial Sloan-Kettering Cancer Center, New York, NY
Postdoctoral Research Fellow in Immunology and Cell Biology, NINDS, National Institutes of Health, Bethesda, MD
Patients may schedule appointments with Dr. Park at:
John Theurer Cancer Center
For more information or to schedule an appointment, call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.